FDA Grants Breakthrough Device Designation for CRISPR Blood Test for Tuberculosis
IntelliGenome’s CRISPR-TB Blood Test, designed to detect Mycobacterium tuberculosis cfDNA, received FDA Breakthrough Device Designation.
Read MorePosted by Andy Lundin | Jan 24, 2025 | Molecular Diagnostics |
IntelliGenome’s CRISPR-TB Blood Test, designed to detect Mycobacterium tuberculosis cfDNA, received FDA Breakthrough Device Designation.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Tuberculosis |
WHO granted prequalification to a tuberculosis molecular diagnostic test that delivers rapid detection of TB and drug resistance.
Read MorePosted by Andy Lundin | Apr 24, 2024 | Tuberculosis |
Revvity launched the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test for latent tuberculosis infection detection.
Read MorePosted by Chris Wolski | Nov 24, 2023 | Tuberculosis |
Though without a standard TB diagnosis, guidelines recommend the use of either the TST or IGRAs to test for latent tuberculosis infections.
Read MorePosted by Andy Lundin | Oct 31, 2023 | Tuberculosis |
An international research consortium has tested a rapid new analytical tool that needs just a blood sample from the fingertip.
Read More